Edition:
United States

Insider Trading: Supernus Pharmaceuticals Inc (SUPN.O)

SUPN.O on Consolidated Issue listed on NASDAQ Global Market

23.80USD
17 Jan 2017
Change (% chg)

$-1.30 (-5.18%)
Prev Close
$25.10
Open
$24.80
Day's High
$24.90
Day's Low
$23.10
Volume
568,135
Avg. Vol
640,904
52-wk High
$27.50
52-wk Low
$9.51

HUDSON FREDERICK M

Institutional Holders

% Shares Owned: 93.83%
# of Holders: 295
Total Shares Held: 46,455,745
3 Mo. Net Change: -96,453
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 13
# Reduced Positions: 10
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Charles Newhall

70 2016 Independent Chairman of the Board

Jack Khattar

53 2005 President, Chief Executive Officer, Secretary, Director

Gregory Patrick

58 2011 Chief Financial Officer, Vice President

Stefan Schwabe

63 2012 Executive Vice-President - Research & Development, Chief Medical Officer

Padmanabh Bhatt

58 2012 Senior Vice President- Intellectual Property, Chief Scientific Officer

Victor Vaughn

57 2013 Senior Vice President - Sales

Georges Gemayel

55 2015 Independent Director

Frederick Hudson

69 2010 Independent Director

William Nuerge

62 2006 Independent Director

John Siebert

75 2011 Independent Director